Browsing category:

TEVA API


Antibiotics, such as Amoxicillin, are extremely effectual when used appropriately prior to surgical procedures. The expiration of the potent antimicrobial drug Moxatag, also known as Amoxicillin, on October 13, 2020, paves the way for additional development of this generic powerhouse. Study results recently released in Infection Control and Hospital Epidemiology reveal that timing is crucial[…]

Read More

Positive Study Results As a common medication prescribed for post-menopausal women to treat and prevent osteoporosis, Raloxifene has now been recognized as a potential viable treatment for both breast and liver cancer. A recently released study, conducted at Oregon State University, demonstrated powerful data touting the use of Raloxifene to treat triple-negative breast cancer (TNBC)[…]

Read More

Known as the brand name Clarinex, as well as Clarinex D 12 Hour, Desloratadine is a steadfast and tolerable treatment for allergies. Desloratadine offers anti-inflammatory benefits, as it is a selective H(1)-receptor antagonist. Known as a safe and effective antihistamine for both adults and children, it comes as no surprise that IMS Health released positive[…]

Read More

The current shortage of the narcotic analgesic Buprenorphine CAS# 52485-79-7, also known as the brand name Buprenex, has created a significant concern. As an injectable medication administered to treat moderate to severe pain, Buprenorphine is not only used for pain management, it is also used to treat addiction to narcotic drugs through a rapid detoxification[…]

Read More

Drug shortages continue to worry healthcare industry workers, especially with the launch of Obamacare on October 1, 2013. While notification has been prompt from the FDA as to which drugs are in danger of becoming in short supply, many medications which are already minimally available have not seen a respite. Falling Short The once planned[…]

Read More

On September 6, 2013 the FDA approved a new indication for the formidable pancreatic cancer drug Paclitaxel. Known as the brand name Abraxane, which is marketed by Celgene, Paclitaxel is now officially indicated for the first-line treatment of patients with metastatic pancreatic cancer. Paclitaxel will be used in a combination treatment, alongside Gemcitabine, to treat[…]

Read More

Tadalafil, also known as Cialis, is making headlines in pharmaceutical news. A study released on March 18, 2013 touted the use of tadalafil alongside finasteride for sizably improving scores for men on the International Prostate Symptom Score. Marketed by Eli Lilly, the patent for Cialis expires on November 21, 2017. The study, which was revealed[…]

Read More

The expiration for the patent of the new formulation of Prozac, also known as the generic drug Fluoxetine Hydrochloride, is slated for November 1, 2017. As a common and effectual antidepressant, Fluoxetine HCl CAS# 56296-78-7, has proven to be a valuable treatment for patients in the United States and worldwide. In fact, antidepressant use in[…]

Read More

Acyclovir, known as the brand name Xerese, is an efficacious medication used to treat herpes labialis. Known commonly as cold sores or fever blisters, this form of the herpes virus is successfully treated with Acyclovir as a combination cream, alongside hydrocortisone. Marketed by Coria Laboratories, the patent for Xerese expires on January 24, 2017. The[…]

Read More